HTD1801: A Promising Oral Therapy Offering Multi-Systemic Benefits for Type 2 Diabetes

Type 2 diabetes (T2D) is a complex and multifaceted disease that rarely exists in isolation. It is often entangled with a web of comorbid conditions, including insulin resistance, dyslipidemia, and liver disease, particularly metabolic dysfunction–associated steatotic liver disease (MASLD). While a wide range of pharmacologic treatments exists, many fall short in comprehensively addressing the spectrum of metabolic dysfunction that patients experience….